| Pharmaceutical active ingredients: |
| CarisoprodolPhenylbutazone |
| Available forms, composition and doses of Myophen: |
| N / A |
| Myophen medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M03BA52 - Carisoprodol, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| S. Charoen Bhaesaj Trading |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Leo-400 | Albendazole | S. Charoen Bhaesaj Trading |
| Loranox | Loratadine | S. Charoen Bhaesaj Trading |
| Mainnox | Dicyclomine Hydrochloride; Mefenamic Acid | S. Charoen Bhaesaj Trading |
| Malugel | Calcium Carbonate; Simethicone | S. Charoen Bhaesaj Trading |
| Myodrine | Acetaminophen; Orphenadrine Citrate | S. Charoen Bhaesaj Trading |
| OMP | Omeprazole | S. Charoen Bhaesaj Trading |
| Painnox | Mefenamic Acid | S. Charoen Bhaesaj Trading |
| Rheumanox | Ibuprofen | S. Charoen Bhaesaj Trading |
| Snoffocin | Norfloxacin | S. Charoen Bhaesaj Trading |
| Stamina | Glucose; Vitamin B | S. Charoen Bhaesaj Trading |